Summary
Paraneoplastic sensorimotor neuropathy occurs in association with many different types of cancer. The clinical findings are heterogeneous, and the pathogenesis is unknown. We have encountered 9 women with breast cancer and shared neurological features that suggest a distinct paraneoplastic syndrome. The syndrome is characterized by upper and lower extremity paresthesias and numbness, itching, muscle weakness and cramps, and in some, radicular symptoms and signs. Serum and CSF inflammatory changes suggested an immune pathogenesis but none had detectable antibodies directed at nervous system elements. Six patients presented with neuropathy 2 months to 8 years before the discovery of the breast cancer. In 7 the neoplastic disease was localized to the breast and axillary lymph nodes. The neurologic course was chronic in all, and while symptoms were annoying, disability was minimal until late. One improved transiently with plasmapheresis, and three had mild transient improvement with treatment of the cancer. Recognition of this paraneoplastic syndrome may forewarn the physician of an underlying breast malignancy.
Similar content being viewed by others
References
Mathews WB: Cryptogenic polyneuritis. Proc Royal Soc Med 45: 667–669, 1952
Rose FC: Discussion on neuropathies in rheumatic disease and steroid therapy. Proc Royal Soc Med 53: 51–53, 1960
Prineas J: Polyneuropathies of undetermined cause. Acta Neurol Scand 46: 4–72, 1970
McLeod JG, Tuck RR, Pollard JDet al.: Chronic polyneuropathy of undetermined cause. J Neurol Neurosurg Psychiat 47: 530–535, 1984
Denny-Brown D: Primary sensory neuropathy with muscular changes associated with carcinoma. J Neurol Neurosurg Psychiat 11: 73–87, 1948
Dyck PJ, Bailey AA, Olszewski J: Carcinomatous neuromyopathy: a case of sensory neuropathy and myopathy with onset three and one-half years before clinical recognition of bronchogenic carcinoma. Can Med Assoc J 79: 913–916, 1958
Horwich MS, Cho L, Porro RS, Posner JB: Subacute sensory neuropathy: a remote effect of carcinoma. Ann Neurol 2: 7–19, 1977
Chalk CH, Windebank AJ, Kimmel DW, McManis PG: The distinctive clinical features of paraneoplastic sensory neuronopathy. Can J Neurol Sci 19: 346–351, 1992
Dayan AD, Croft PB, Wilkinson M: Association of carcinomatous neuromyopathy with different histological types of carcinoma of the lung. Brain 88: 435–488, 1965
Croft PB, Wilkinson M: The course and prognosis in some types of carcinomatous neuromyopathy. Brain 92: 1–8, 1969
Wilkinson PC: Serological findings in carcinomatous neuromyopathy. Lancet i: 1301–1303, 1964
Wilkinson PC, Zeromski J: Immunofluorescent detection of antibodies against neurones in sensory carcinomatous neuropathy. Brain 88: 529–538, 1965
Croft PB, Henson RA, Urich H, Wilkinson PC: Sensory neuropathy with bronchial carcinoma: a study of four cases showing serological abnormalities. Brain 88: 501–514, 1965
Anderson NE, Rosenblum MK, Graus Fet al.: Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer. Neurology 38: 1391–1398, 1988
Graus F, Elkon KB, Cordon-Cardo C, Posner JB: Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor. Am J Med 80: 45–51, 1986
Budde-Steffen C, Anderson NE, Rosenblum MK, Posner JB: Expression of an antigen in small cell lung carcinoma lines detected by antibodies from patients with paraneoplastic dorsal root ganglionitis. Cancer Res 48: 430–434, 1988
Dalmau J, Furneaux HM, Gralla RJet al.: Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer — a quantitative Western blot analysis. Ann Neurol 27: 544–552, 1990
Dalmau J, Graus F, Rosenblum K, Posner JB: Anti-Hu-associated paraneoplastic encephalitis/sensory neuronopathy; a clinical study of 71 patients. Medicine 71: 59–72, 1992
Croft PB, Wilkinson M: The incidence of carcinomatous neuromyopathy in patients with various types of carcinoma. Brain 88: 427–434, 1965
Trojaborg W, Frantzen E, Anderson I: Peripheral neuropathy and myopathy associated with carcinoma of the lung. Brain 92: 71–82, 1969
Peterson K, Rosenblum MK, Kotanides H, Posner JB: Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 42: 1931–1937, 1992
Osuntokun BO, Adeuja AOG, Schoenberg BSet al.: Neurological disorders in Nigerian Africans: a community based study. Acta Neurol Scand 75: 13–21, 1987
Bharucha NE, Bharucha AE, Bharucha EP: Prevalence of peripheral neuropathy in the Parsi community of Bombay. Neurology 41: 1315–1317, 1991
Croft PB, Wilkinson M: Carcinomatous neuromyopathy. Its incidence in patients with carcinoma of the lung and carcinoma of the breast. Lancet i: 184–188, 1963
Lehtinen JM, Uusitupa M, Siitonen O, Pyorala K: Prevalence of neuropathy in newly diagnosed NIDDM and non-diabetic control subjects. Diabetes 38: 1307–1313, 1989
Boring CC, Squires TS, Tong T: Cancer statistics, 1992. Ca —A Cancer Journal for Clinicians 42: 19–38, 1992
Steiner I, Siegal T: Muscle cramps in cancer patients. Cancer 63: 574–577, 1989
Layzer RB: Neuromuscular manifestations of systemic disease. FA Davis Company, Philadelphia, 1985, pp 19–22
Brain R, Henson RA: Neurologic syndromes associated with carcinomas — The carcinomatous neuromyopathies. Lancet 2: 971–975, 1958
Bruyn RPM: Paraneoplastic polyneuropathy. In: Mathews WB (ed) Handbook of clinical neurology. Elsevier Science Publishers, New York, 1987, Vol 51, pp 465–473.
Hensen RA, Urich H: Cancer and the nervous system: the neurological manifestations of systemic malignant disease. Blackwell Scientific Publications, London, 1982, pp 368–405
Campbell MJ, Paty DW: Carcinomatous neuromyopathy: 1. Electrophysiological studies. An electrophysiological and immunological study of patients with carcinoma of the lung. J Neurol Neurosurg Psychiat 37: 131–141, 1974
Croft PB, Urich H, Wilkinson M: Peripheral neuropathy of sensorimotor type associated with malignant disease. Brain 90: 31–66, 1967
Asbury AK, Johnson PC: Pathology of peripheral neves. WB Saunders, Philadelphia, 80–82, 1978
McLeod JG: Carcinomatous neuropathy. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R (eds) Peripheral neuropathy. WB Saunders, Philadelphia, 2180–2191, 1984
Hildebrand J, Coers C: The neuromuscular function in patients with malignant tumors: electromyographic and histological study. Brain 90: 67–82, 1967
Barron SA, Heffner RR: Weakness in malignancy: evidence for a remote effect of tumor on distal neurons. Ann Neurol 4: 268–274, 1978
DeWit R, Hoek FJ, Bakker PJM, Veenhoff CHN: The value of MCA, CA 15-3, CEA and CA-125 for discrimination between metastatic breast cancer and adenocarcinoma of other primary sites. J Intern Med 229: 463–466, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Peterson, K., Forsyth, P.A. & Posner, J.B. Paraneoplastic sensorimotor neuropathy associated with breast cancer. J Neuro-Oncol 21, 159–170 (1994). https://doi.org/10.1007/BF01052900
Issue Date:
DOI: https://doi.org/10.1007/BF01052900